Dual Frequency Low-Level Laser Therapy in Myofascial Trigger Points of Upper Trapezius
NCT ID: NCT07137728
Last Updated: 2025-09-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
32 participants
INTERVENTIONAL
2025-08-25
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
i)Does DF-LLLT reduce pain intensity on the Visual Analog Scale (VAS) more than sham laser therapy? ii)Does DF-LLLT improve functional status (Neck Disability Index) and cervical range of motion more than sham laser therapy?
Researchers will compare DF-LLLT plus conventional therapy to sham laser plus conventional therapy to see if DF-LLLT has greater therapeutic effects.
Participants will:
1. Receive either DF-LLLT or sham laser therapy twice weekly for 4 weeks
2. Perform a standardized stretching and strengthening exercise program for the neck and shoulders.
3. Attend clinic visits at baseline, week 2, and week 4 for assessments of pain, function, and cervical mobility.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficacy of Low-level Laser on Cervical Myofascial Pain Syndrome
NCT01516502
Myofascial Release vs. Stretching With Ultrasound for Trapezius Trigger Points in Athletes: A Randomized Clinical Trial
NCT07002593
Instrument-Assisted Soft Tissue Mobilization Versus High Power Pain Threshold Ultrasound For Trapezius Myofascial Trigger Points
NCT05288933
Interferential Current And Trapezius Myofascial Trigger Points
NCT05275634
High Intensity Laser Versus Ischemic Compression on Myofascial Trigger Points in the Upper Trapezius
NCT06552780
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Low-level laser therapy (LLLT) is a non-invasive photobiomodulation technique shown to reduce pain and inflammation and promote tissue healing. Dual frequency LLLT may provide enhanced therapeutic effects compared to single frequency LLLT by delivering both continuous and pulsed light energy to targeted tissues. However, clinical evidence for its use in upper trapezius MTrPs is limited.
This single-blinded randomized controlled trial will recruit 32 male and female participants aged 20-55 years who meet the diagnostic criteria for MTrPs according to Simons' guidelines. Participants will be randomly assigned to one of two groups:
Experimental group: DF-LLLT (830 nm, 100 mW/cm², 9.12 Hz, 5 J/cm²) applied perpendicularly over each identified MTrP for 3 minutes 9 seconds per point, twice weekly for 4 weeks, plus a standardized stretching and strengthening program.
Control group: Sham laser therapy with identical appearance and application time but without light emission, plus the same exercise program.
Primary and secondary outcomes will be assessed at baseline, week 2, and week 4:
Primary outcome: Change in pain intensity measured using the Visual Analog Scale (VAS)
Secondary outcomes: Change in functional status (Neck Disability Index) and change in cervical range of motion (flexion, extension, lateral flexion, and rotation) measured with a goniometer.
The study aims to determine whether DF-LLLT provides superior pain relief, functional improvement, and mobility gains compared to sham laser therapy when combined with conventional exercises. Statistical analysis will be performed using SPSS 21.0, with significance set at p ≤ 0.05.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
1. Experimental group:
Dual frequency low-level laser therapy plus conventional therapy.
2. Control group:
Sham laser therapy plus conventional therapy.
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dual Frequency Low-Level Laser Therapy + Conventional Therapy
Participants will receive dual frequency low-level laser therapy (DF-LLLT) at 830 nm, 100 mW/cm², 9.12 Hz, 5 J/cm², applied perpendicularly over each identified myofascial trigger point in the upper trapezius muscle for 3 minutes 9 seconds per point, twice weekly for 4 weeks. In addition, they will perform a standardized stretching and strengthening exercise program for the neck and shoulders.
Dual Frequency Low-Level Laser Therapy
DF-LLLT (830 nm, 100 mW/cm², 9.12 Hz, 5 J/cm²) applied over each identified trigger point for 3 minutes 9 seconds per point, twice weekly for 4 weeks.
Conventional Therapy (Stretching and Strengthening Program)
A standardized physiotherapy program including stretching and strengthening exercises for the cervical and shoulder muscles. The program is performed under physiotherapist supervision twice weekly for 4 weeks. Exercises are identical across both study arms and include stretching of the upper trapezius and strengthening of the neck and scapular stabilizer muscles.
Sham Laser + Conventional Therapy
Participants will receive sham laser therapy with identical appearance, sounds, and application time as the experimental laser but without light emission. In addition, they will perform the same standardized stretching and strengthening exercise program for the neck and shoulders.
Sham Laser
Inactive laser device identical in appearance and sound to the active laser but without light emission, applied for 3 minutes 9 seconds per point, twice weekly for 4 weeks.
Conventional Therapy (Stretching and Strengthening Program)
A standardized physiotherapy program including stretching and strengthening exercises for the cervical and shoulder muscles. The program is performed under physiotherapist supervision twice weekly for 4 weeks. Exercises are identical across both study arms and include stretching of the upper trapezius and strengthening of the neck and scapular stabilizer muscles.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dual Frequency Low-Level Laser Therapy
DF-LLLT (830 nm, 100 mW/cm², 9.12 Hz, 5 J/cm²) applied over each identified trigger point for 3 minutes 9 seconds per point, twice weekly for 4 weeks.
Sham Laser
Inactive laser device identical in appearance and sound to the active laser but without light emission, applied for 3 minutes 9 seconds per point, twice weekly for 4 weeks.
Conventional Therapy (Stretching and Strengthening Program)
A standardized physiotherapy program including stretching and strengthening exercises for the cervical and shoulder muscles. The program is performed under physiotherapist supervision twice weekly for 4 weeks. Exercises are identical across both study arms and include stretching of the upper trapezius and strengthening of the neck and scapular stabilizer muscles.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of myofascial pain based on Simons criteria.
* At least two trigger points in the upper trapezius muscle.
* Pain duration ≥ 3 months.
* VAS pain score ≥ 5.
* Limited cervical range of motion due to trigger points.
Exclusion Criteria
* Use of anticoagulants.
* Bleeding disorders or dermatological diseases at treatment site.
* History of infectious, inflammatory, tumoral, cardiopulmonary, psychiatric, or systemic diseases.
* Kellgren stage 3-4 cervical osteoarthritis or cervical disc herniation causing radiculopathy.
* Diagnosis of fibromyalgia.
* Inability to follow instructions or complete questionnaires.
20 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Lahore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UOL/IREB/25/09/0006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.